Skip to main content
Global Desk
Advertise About Contact Ethics
Philifoth logo
Philifoth
News Network
  • Home
  • World⌄
    • Africa
    • Americas
    • Asia
    • Europe
    • Middle East
  • Politics⌄
    Trump Goon Bragged of Giving Sex-Scandal CEO ‘Easy Access’ to President Politics

    Trump Goon Bragged of Giving Sex-Scandal CEO ‘Easy Access’ to Pr…

    Chhatarpur on edge as Yadav Mahasabha, Bageshwar Dham followers face off over Shastri's remarks Politics

    Chhatarpur on edge as Yadav Mahasabha, Bageshwar Dham followers …

    Douglas: New cell phone brings tortuous Tuesday Politics

    Douglas: New cell phone brings tortuous Tuesday

    'Commerce Has the Pen': Scott Bessent Points Finger at Howard Lutnick in Growing Nvidia Scandal Politics

    'Commerce Has the Pen': Scott Bessent Points Finger at Howard Lu…

  • Business
  • Technology
  • Sports
  • Lifestyle⌄
    • Health
    • Travel
    • Food
    • Culture
  • Jobs
  • Archive
EN
English ✓ Español Français Deutsch
Home / Health / Article
Health Source-linked briefing

Alnylam Pharmaceuticals (NASDAQ:ALNY) Shares Climb 6.9% - Still a Buy?

Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price Up 6.9% - Should You Buy?

Marketbeat
Original contributor via Market Beat
| November 13, 2026 | 1 min read | Updated Nov 14, 5:01 AM
Alnylam Pharmaceuticals (NASDAQ:ALNY) Shares Climb 6.9% - Still a Buy?
Image supplied with the source report: Market Beat.

Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price Up 6.9% - Should You Buy?

Source disclosure

This is a source-linked briefing. Read the original report from Market Beat .

Health alnylam pharmaceuticals percent advance instant alerts
STORY FILE
Section
Health
Source
Market Beat
Last Updated
Nov 14, 2026 5:01 AM
RELATED STORIES
After a Stroke: 4 Common Challenges and How Rehabilitation Can Help

After a Stroke: 4 Common Challenges and How Rehabilitation Can Help

Health
Zevra Therapeutics (NASDAQ:ZVRA) Shares Gap Down - Should You Sell?

Zevra Therapeutics (NASDAQ:ZVRA) Shares Gap Down - Should You Sell?

Health
Amodei and Dimon hosting livestream ahead of Anthropic's IPO

Amodei and Dimon hosting livestream ahead of Anthropic's IPO

Health
Deloitte Ends Weight-Loss Drug Coverage for US Staff in 2027

Deloitte Ends Weight-Loss Drug Coverage for US Staff in 2027

Health
Philifoth logo
Philifoth

Curated news discovery with visible sources, concise briefings, and direct links to original reporting.

SECTIONS

  • World
  • Politics
  • Business
  • Technology
  • Sports
  • Health

COMPANY

  • About Us
  • Advertise
  • Contact
  • Ethics Policy

MORE

  • RSS Feed
  • News Archive
  • Search
© 2026 Philifoth News. All Rights Reserved. Privacy Policy Terms of Service Cookie Settings
⌂ Home 🌍 World • Video • Contact